Stem cell factor suppressed IL-33-induced MHC class II expression in murine bone marrow-derived mast cells

Allergol Int. 2019 Apr;68(2):264-267. doi: 10.1016/j.alit.2018.08.009. Epub 2018 Sep 21.

Authors

Tomonobu Ito¹, Chizu Egusa², Tatsuo Maeda², Takafumi Numata², Nobuhiro Nakano³, Chiharu Nishiyama⁴, Ryoji Tsuboi²

Affiliations

¹ Department of Dermatology, Tokyo Medical University, Tokyo, Japan. Electronic address: tomonobu@tokyo-med.ac.jp.
² Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
³ Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan.
⁴ Department of Biological Science and Technology, Tokyo University of Science, Tokyo, Japan.

PMID: 30249379
DOI: 10.1016/j.alit.2018.08.009

No abstract available

Publication types

Letter

MeSH terms

Animals
Bone Marrow
Cells, Cultured
Histocompatibility Antigens Class II / immunology*
Interleukin-33 / immunology*
Mast Cells / drug effects*
Mast Cells / immunology
Mice, Inbred BALB C
Stem Cell Factor / pharmacology*

Substances

Histocompatibility Antigens Class II
Il33 protein, mouse
Interleukin-33
Stem Cell Factor